Smoking and Mental Health Statistics for 2026
Smoking and mental health statistics for 2026 reveal a relationship that is both pervasive and poorly understood by the general public. Cigarette smoking prevalence is two to three times higher among people with any mental illness than in the general adult population — and rises to nearly five times higher among those with schizophrenia, bipolar disorder, PTSD, or substance use disorders (NIDA, 2023). In the United States, 35% of all cigarettes are smoked by people who have a mental health condition, despite this group representing only about 21% of the adult population (CDC, 2024).
For a long time, smoking among people with mental illness was rationalised as self-medication or an untreatable behaviour. The current evidence overturns both assumptions: nicotine does not improve mental health outcomes long-term, and people with mental illness can and do quit successfully — with outcomes for mental health that are generally better, not worse, after cessation. This data roundup synthesises the statistics on smoking prevalence, mental health conditions, and cessation outcomes from the CDC, NIDA, WHO, the American Lung Association, and peer-reviewed research through 2026.
Prevalence Overview: Mental Illness and Smoking Rates
The co-occurrence of smoking and mental illness is one of the most well-documented patterns in tobacco epidemiology. Despite the significant decline in overall US smoking rates from roughly 42% in 1964 to approximately 11.5% in 2024, smoking rates among people with mental illness have remained persistently elevated.
| Population Group | Current Smoking Rate | Source |
|---|---|---|
| US general adult population | ~11.5–14% | CDC, 2024 |
| Adults with any behavioral/mental health condition | ~23% | American Lung Association, 2024 |
| Adults with depression | ~23–30% | CDC, 2024; NIDA, 2023 |
| Adults with anxiety disorder | ~25–30% | NIDA, 2023 |
| Adults with PTSD | ~40–50% | NIDA, 2023 |
| Adults with bipolar disorder | 50–70% | NIDA, 2023 |
| Adults with schizophrenia | 70–85% | NIDA, 2023 |
A critical statistic underlining the disproportionate impact: although people with mental health conditions represent approximately 21% of US adults, they account for 35% of all cigarette consumption (CDC, 2024) — a ratio reflecting both higher prevalence rates and heavier smoking habits within this population.
Smoking Rates by Mental Health Condition
The relationship between smoking and mental illness is not uniform — rates vary dramatically by diagnosis and severity. Understanding these differences is important for designing appropriate cessation support.
| Mental Health Condition | Smoking Rate | vs General Population |
|---|---|---|
| Schizophrenia | 70–85% | ~5–6x higher |
| Bipolar disorder | 50–70% | ~4–5x higher |
| PTSD | 40–50% | ~3–4x higher |
| Major depressive disorder | 23–30% | ~2x higher |
| Anxiety disorders | 25–30% | ~2x higher |
| Any behavioral health condition | ~23% | ~1.6x higher |
The Depression–Nicotine Link: Evidence and Data
The relationship between smoking and depression is well-established in both directions, and represents one of the most intensively studied mental health–nicotine associations in the literature.
How Common Is Depression Among Smokers?
- People who smoke are approximately twice as likely to have depression as non-smokers (PMC, 2016; consistent with NIDA, 2023 updates).
- Among heavy smokers (20+ cigarettes/day), the odds ratio for depression rises to approximately fourfold versus never-smokers.
- 35% of people who smoke cigarettes have a mental health condition (CDC, 2024).
The Bidirectional Relationship
Research does not support a simple causal direction. Longitudinal studies suggest both pathways operate:
- Depression increases smoking risk: People with depression may use nicotine for its acute mood-altering effects (transient dopamine release). Depression also impairs the motivation and executive function needed to sustain a quit attempt.
- Smoking may worsen depression: Nicotine’s chronic dysregulation of dopamine and serotonin pathways, combined with the cyclical withdrawal-relief cycle, may sustain or deepen depressive symptoms over time. People mistake relief of nicotine withdrawal for a mood benefit of smoking — a key cognitive distortion that perpetuates use.
Does Quitting Help Depression?
A meta-analysis of 26 tobacco treatment studies (Randomised trials and prospective studies) found that quitting smoking was significantly associated with decreased depression, anxiety, and stress, and with improved quality of life and positive affect, compared with continuing to smoke (ScienceDirect, 2025). The effect sizes for mood improvement were comparable to those seen with antidepressant medications in some analyses — a striking finding that challenges the self-medication narrative.
Anxiety Disorders and Smoking Statistics
Anxiety disorders are among the most common mental health diagnoses, and their relationship with smoking is closely parallel to the depression pattern.
- Approximately 25–30% of people with anxiety disorders are current smokers — roughly double the general population rate.
- People with anxiety disorders who smoke report using cigarettes specifically to manage anxiety symptoms — a form of self-medication that is counterproductive over the medium term.
- The nicotine withdrawal cycle itself generates anxiety-like symptoms (irritability, restlessness, difficulty concentrating), which smokers may misattribute to their underlying disorder rather than nicotine dependence.
- Panic disorder shows a particularly strong association with smoking: smokers are more likely to develop panic disorder, and panic disorder is associated with higher smoking relapse rates during quit attempts.
- A 2022 longitudinal study found that cessation was associated with significantly reduced anxiety and improved sleep at 6-month follow-up, with mental health benefits appearing even in the first 4–8 weeks after quitting.
Schizophrenia and Bipolar Disorder: The Highest Rates
People with schizophrenia have the highest smoking rates of any psychiatric group — with 70–85% being current smokers, and heavy smoking being the norm rather than the exception.
Schizophrenia
Several hypotheses explain the extraordinarily high smoking rate in schizophrenia:
- Self-medication of positive symptoms: Nicotine stimulates nicotinic acetylcholine receptors that are implicated in auditory hallucination processing.
- Self-medication of antipsychotic side effects: Nicotine reduces sedation and extrapyramidal side effects (movement disorders) caused by antipsychotic medications.
- Cognitive effects: Nicotine provides transient improvements in working memory and attention — functions that are impaired in schizophrenia.
- Social environment: Inpatient psychiatric units historically had high smoking cultures; peer and institutional norms facilitated smoking initiation and maintenance.
Despite the complexity, people with schizophrenia can quit smoking. Meta-analyses show that intensive, tailored cessation programmes achieve quit rates in this population — though lower than in the general population, the benefits in cardiovascular health are substantial. Tobacco-related diseases account for approximately 53% of deaths among people with schizophrenia (NIDA, 2023).
Bipolar Disorder
With smoking rates of 50–70%, bipolar disorder is the second highest-risk psychiatric group. Tobacco-related diseases account for approximately 48% of deaths among people with bipolar disorder (NIDA, 2023). The elevated smoking rate is associated with:
- Higher impulsivity during manic/hypomanic phases increasing initiation and relapse risk.
- Self-medication of depressive phases.
- Interactions between lithium and other mood stabilisers and nicotine metabolism.
Mortality Impact: How Smoking Shortens Lives in This Group
The combination of high smoking rates and underlying health vulnerabilities creates a severe mortality disadvantage for people with serious mental illness (SMI).
| Mental Health Condition | % of Deaths Attributable to Tobacco-Related Disease |
|---|---|
| Schizophrenia | ~53% |
| Depression | ~50% |
| Bipolar disorder | ~48% |
These mortality figures underscore that the biggest single intervention to extend life expectancy for people with serious mental illness is smoking cessation — exceeding the impact of improvements in psychiatric medication management alone.
People with mental illness die on average 10–25 years earlier than the general population; a substantial portion of this premature mortality gap is attributable to tobacco-related cardiovascular disease, COPD, and cancer — all of which are directly caused by smoking.
Youth: Mental Health and Nicotine Use Data
The relationship between youth nicotine use and mental health is particularly concerning given the vulnerability of the developing brain.
- 42.1% of youth current e-cigarette users report moderate-to-severe depression and anxiety symptoms, compared with 21.0% of non-using youth (CDC, 2024).
- A 2020–2023 longitudinal study across Canada, England, and the US found that mental health symptom burden was consistently higher among youth nicotine users across all three countries and all time points.
- Youth with ADHD have disproportionately high smoking initiation rates, consistent with the self-medication and impulsivity patterns seen in adults with SMI.
- Depression is a significant predictor of smoking relapse in adolescent quit attempts.
For full data on youth tobacco use trends, see our article on teen and young adult smoking statistics for 2026.
What Happens to Mental Health When You Quit Smoking?
One of the most consistently misunderstood topics in smoking cessation is the effect of quitting on mental health. A pervasive myth — held by many healthcare providers as well as patients — is that quitting smoking worsens mental health, particularly for people with depression or anxiety.
The evidence directly contradicts this:
- A 2025 randomised trial published in Journal of Health Economics found that smoking cessation was associated with significant reductions in depressive symptoms at 6-month follow-up, with effects comparable in magnitude to receiving a course of CBT (ScienceDirect, 2025).
- The meta-analysis of 26 cessation treatment studies found improvements in depression, anxiety, stress, positive affect, and quality of life associated with successful cessation (NIDA, 2023).
- The mechanism: much of the “mood benefit” that smokers perceive from cigarettes is actually relief of nicotine withdrawal. As time from last cigarette increases, inter-cigarette anxiety and irritability resolve — and the smoker misattributes this as a benefit of smoking rather than an iatrogenic effect of dependence.
- After the first 4–8 weeks of cessation, when withdrawal symptoms resolve, the majority of successful quitters report mood that is better than their mood while smoking.
Barriers to Cessation in People with Mental Illness
Despite the evidence that quitting improves mental health outcomes, people with mental illness face specific barriers to successful cessation that need to be understood by clinicians and health system designers:
- Clinician underestimation: Many mental health clinicians historically have not prioritised cessation, perceiving it as less urgent or feasible in this population.
- Medication interactions: As noted, some antipsychotics are metabolised faster in smokers. Quitting raises drug blood levels, requiring close monitoring.
- Weight gain concerns: People with schizophrenia and bipolar disorder already face weight gain from antipsychotic medications; cessation-related weight gain is a significant barrier and deterrent.
- Social environments: Inpatient and residential settings with high smoking peer norms create maintenance environments for smoking behaviour.
- Nicotine dependence severity: People with SMI tend to be heavier smokers with deeper addiction, requiring higher-intensity cessation support.
- Access barriers: Lower income, transportation difficulties, and complex care needs create access barriers to traditional cessation services.
Digital cessation tools can partially address the access barriers by delivering support at home, on-demand, without requiring clinic attendance. The evidence for app-based cessation in this population is limited but growing — see our analysis of quit smoking app effectiveness research data for the broader evidence base. For practical quit strategies applicable to people with mental health conditions, our guide to the most effective ways to quit smoking and nicotine withdrawal management guide provide evidence-based approaches.
Frequently Asked Questions
How much more likely are people with mental illness to smoke?
Smoking prevalence is two to three times higher in people with any mental illness compared with the general population. The disparity is even greater for specific conditions: schizophrenia (70–85% smoking rate, approximately 5–6x the general population rate), bipolar disorder (50–70%, approximately 4–5x), PTSD (40–50%, approximately 3–4x), and depression and anxiety disorders (approximately 2x). People with mental health conditions account for 35% of all cigarettes smoked in the US, despite representing 21% of the adult population.
Does quitting smoking worsen depression or anxiety?
No — the evidence consistently shows the opposite. A meta-analysis of 26 cessation studies found that quitting smoking was significantly associated with reduced depression, anxiety, and stress, and improved quality of life. A 2025 randomised trial found mental health improvements following cessation comparable in effect size to a course of CBT. What smokers perceive as a mood benefit from smoking is primarily relief of nicotine withdrawal — not a genuine improvement beyond their baseline. After withdrawal resolves (typically 4–8 weeks), most successful quitters report better mood than while smoking.
Why do so many people with schizophrenia smoke?
The 70–85% smoking rate in schizophrenia is driven by multiple factors. Nicotine stimulates receptors involved in auditory hallucination processing and provides transient improvements in working memory and attention — cognitive functions impaired by the disorder. Nicotine also reduces motor side effects of antipsychotic medications. Historical inpatient culture and social norms also played a significant role in initiation. Tobacco-related diseases account for approximately 53% of deaths in people with schizophrenia, making cessation the single largest potential life-extension intervention in this group.
Is smoking a cause or a consequence of depression?
Both pathways are supported by longitudinal research. Depression increases smoking risk (people use nicotine to manage depressive symptoms) and smoking may worsen or maintain depression over time (through nicotine’s chronic dysregulation of dopamine and serotonin, and the withdrawal-relief cycle). Heavy smokers have approximately four times the odds of depression compared with non-smokers. The causal relationship is bidirectional and complex, which is why cessation support for people with depression should include mental health-informed components.
Can people with mental illness successfully quit smoking?
Yes. While quit rates in people with serious mental illness are lower than in the general population with standard cessation support, intensive and tailored programmes achieve meaningful quit rates even in schizophrenia — a group often assumed to be unable to quit. Key success factors include: higher-intensity support; combination of pharmacotherapy (varenicline is effective in this group) and behavioural support; collaboration with the mental health treatment team; and monitoring of psychiatric medication levels, which can change with smoking cessation.
Do people with mental illness smoke more cigarettes per day?
Yes. People with mental illness are not only more likely to smoke but also tend to smoke more heavily. This is especially true in schizophrenia, where heavy smoking (20+ cigarettes/day) is common. This higher consumption level reflects deeper nicotine dependence, which in turn means higher-dose or combination NRT, and potentially longer treatment courses, are more likely to be required for successful cessation in this population.
How does smoking affect anxiety in the long term?
In the long term, smoking increases anxiety rather than reducing it. The nicotine withdrawal cycle generates anxiety-like symptoms between cigarettes (irritability, restlessness, difficulty concentrating), which the smoker relieves by smoking — creating the false impression that smoking treats anxiety. Chronically, nicotine dysregulates the serotonergic and noradrenergic systems involved in anxiety. Longitudinal studies show that cessation is associated with significantly reduced anxiety at 6-month follow-up, once the initial withdrawal period has passed.